CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations · Executive or director change · Shareholder vote results
- 4 Open-market buy CEO and Director bought 124 shares at $3.00 ($372)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
Page 26 of 38 · 755 filings